1. Maximilian Weiss et al. COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREALÚNTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE. Retina 2018 Dec;38(12):2293-2300.
2. Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2021 Feb 27;9(1):62-79. doi: 10.1016/j.gendis.2021.02.009. PMID: 35005108; PMCID: PMC8720701.
3. Genentech. (n.d.). Understanding DME. Genentech: Breakthrough Science. One Moment, One Day, One Person at a Time. Accessed on 05 August, 2026 from https://www.gene.com/stories/understanding-dm.
4. Puli, L., Piona, C., Mancioppi, V., Passanisi, S., Kavanagh, S., & Donaghue, K. C. (2026). Optimal screening practices for diabetic retinopathy in children and adolescents with type 1 diabetes: A systematic review to inform global screening guidance. Diabetes Research and Clinical Practice, 238, Article 113385. https://doi.org/10.1016/j.diabres.2026.113385
5. Hanany, M., Rivolta, C., & Sharon, D. (2020). Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases. Proceedings of the National Academy of Sciences of the United States of America, 117(5), 2710–2716. https://doi.org/10.1073/pnas.1913179117